These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6238728)

  • 21. Starch gel electrophoresis of phosphofructokinase in red cells.
    Niessner H; Beutler E
    Biochem Med; 1974 Jan; 9(1):73-6. PubMed ID: 4274001
    [No Abstract]   [Full Text] [Related]  

  • 22. Erythrocyte phosphofructokinase and glucose-6-phosphate dehydrogenase in leukemia.
    Kwiatkowska J; Zatoński W; Baranowski T
    Clin Chim Acta; 1973 May; 45(4):403-8. PubMed ID: 4269764
    [No Abstract]   [Full Text] [Related]  

  • 23. Muscle phosphofructokinase deficiency in man: expression of the defect in blood cells and cultured fibroblasts.
    Kahn A; Weil D; Cottreau D; Dreyfus JC
    Ann Hum Genet; 1981 Feb; 45(1):5-14. PubMed ID: 6459054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasmodium berghei: acid-insensitive phosphofructokinase in infected mouse erythrocytes.
    Sander BJ; Lowery MS; Kruckeberg WC
    Exp Parasitol; 1982 Feb; 53(1):11-6. PubMed ID: 6459948
    [No Abstract]   [Full Text] [Related]  

  • 25. [Erythrocyte phosphofructokinase activity in children with different forms of acute pneumonia during the 1st year of life].
    Veprins'kaia IP
    Pediatr Akus Ginekol; 1972; 1():13. PubMed ID: 4266879
    [No Abstract]   [Full Text] [Related]  

  • 26. Kinetic properties of mutant enzymes in erythrocyte phosphofructokinase deficiency and erythrocyte pyruvate kinase deficiency.
    Shimizu T; Kuwajima M; Kono N; Mineo I; Sumi S; Yonezawa T; Nonaka K; Tarui S
    Med J Osaka Univ; 1983 Mar; 33(3-4):49-58. PubMed ID: 6225942
    [No Abstract]   [Full Text] [Related]  

  • 27. Association behaviour of human erythrocyte phosphofructokinase. Dependence of molecular weight on enzyme concentration as analyzed by frontal gel chromatography.
    Zimmermann G; Schellenberger W; Wenzel KW; Hofmann E
    Acta Biol Med Ger; 1978; 37(4):527-35. PubMed ID: 153695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and some properties of phosphofructokinase from Ehrlich ascites tumor cells.
    Sumi T; Ui M
    Biochim Biophys Acta; 1972 May; 268(2):354-63. PubMed ID: 4260318
    [No Abstract]   [Full Text] [Related]  

  • 29. The stimulation of phosphofructokinase from human erythrocytes by fructose 2,6-bisphosphate.
    Heylen A; Van Schaftingen E; Hers HG
    FEBS Lett; 1982 Jun; 143(1):141-3. PubMed ID: 6214425
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of cortisol on erythrocyte and reticulocyte enzymes: modulation of phosphofructokinase properties.
    Kwiatkowska D; Szajerka G; Kwiatkowska J
    Arch Immunol Ther Exp (Warsz); 1983; 31(3):381-7. PubMed ID: 6228205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A liver-type mutation in a case of pronounced erythrocyte phosphofructokinase deficiency without clinical expression.
    Etiemble J; Simeon J; Buc HA; Picat C; Boulard M; Boivin P
    Biochim Biophys Acta; 1983 Sep; 759(3):236-42. PubMed ID: 6224515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of 2,3-DPG on red cell phosphofructokinase.
    Beutler E; Guinto E
    FEBS Lett; 1973 Nov; 37(1):21-2. PubMed ID: 4270992
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of in vivo hyperoxia on erythrocytes: VII. Inhibition of RBC phosphofructokinase.
    Timms R; Mengel CE
    Aerosp Med; 1968 Jan; 39(1):71-3. PubMed ID: 4229600
    [No Abstract]   [Full Text] [Related]  

  • 34. Self-association of human erythrocyte phosphofructokinase. Kinetic behaviour in dependence on enzyme concentration and mode of association.
    Wenzel KW; Kurganov BI; Zimmermann G; Yakovlev VA; Schellenberger W; Hofmann E
    Eur J Biochem; 1976 Jan; 61(1):181-90. PubMed ID: 128461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter: Red-cell phosphofructokinase deficiency.
    Boulard MR; Meienhofer MC; Bois M; Reviron M; Najean Y
    N Engl J Med; 1974 Oct; 291(18):978-9. PubMed ID: 4278172
    [No Abstract]   [Full Text] [Related]  

  • 36. Endogenous phosphorylation of soluble enzymes in human red cells. Cyclic 3',5'-AMP-dependent phosphorylation of phosphofructokinase without detectable regulatory effect.
    Lagrange JL; Marie J; Cottreau D; Fischer S; Kahn A
    Biochim Biophys Acta; 1980 Mar; 612(1):213-25. PubMed ID: 6244850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and properties of 1-phosphofructokinase from Clostridium pasteurianum.
    van Hugo H; Gottschalk G
    Eur J Biochem; 1974 Oct; 48(2):455-63. PubMed ID: 4280969
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of activators and inhibitors of SH groups on purified phosphofructokinase activity in hemolysates and intact erythrocytes].
    Torliński L; Karoń H; Torlińska T
    Acta Haematol Pol; 1984; 15(3-4):125-36. PubMed ID: 6242208
    [No Abstract]   [Full Text] [Related]  

  • 39. Sedoheptulose-7-phosphate kinase activity of phosphofructokinase from the different tissues of rabbit.
    Karadsheh NS; Tejwani GA; Ramaiah A
    Biochim Biophys Acta; 1973 Nov; 327(1):66-81. PubMed ID: 4272358
    [No Abstract]   [Full Text] [Related]  

  • 40. Immunologic study of the age-related loss of activity of six enzymes in the red cells from newborn infants and adults--evidence for a fetal type of erythrocyte phosphofructokinase.
    Kahn A; Boyer C; Cottreau D; Marie J; Boivin P
    Pediatr Res; 1977 Apr; 11(4):271-6. PubMed ID: 139592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.